
# Enum: CommonNameEnum




URI: [https://w3id.org/pcdc/model/CommonNameEnum](https://w3id.org/pcdc/model/CommonNameEnum)


## Other properties

|  |  |  |
| --- | --- | --- |

## Permissible Values

| Text | Description | Meaning | Other Information |
| :--- | :---: | :---: | ---: |
| E2A/PBX1 t(1;19) | A cytogenetic abnormality that involves a translocation between chromosomes 1 and 19. | ncit:C128654 |  |
| ETV6-RUNX1 t(12;21)(p13;q22)(formerly TEL-AML1) | A translocation between chromosomes 12 and 21 involved in TEL-AML1 oncogene formation. The translocation produces a chimeric gene encoding a protein consisting of the N-terminal HLH domain of the TEL ETS-like transcription factor fused with a nearly complete AML1 protein. t(12;21) is the most frequent translocation causing ALL, accounting for 20% of ALL cases. | ncit:C13727 |  |
| iAMP21 | A cytogenetic abnormality that refers to the allelic gain of an internal part of chromosome 21. It is a rare high-risk chromosomal abnormality that occurs in approximately 2-5% of pediatric patients with B-cell precursor Acute Lymphoblastic Leukemia. This abnormality has been associated with a poor outcome in patients treated by standard protocols. | ncit:C124874 |  |
| MLL Rearrangement (Translocation) | A cytogenetic abnormality that refers to any translocation involving the MLL (KMT2A) gene. | ncit:C167144 |  |
| t(4;11)(q21;q23) / MLL-MLLT2(AF4) | A chromosomal abnormality consisting of the translocation of 4q21 with 11q23. | ncit:C36365 |  |
| t(8;14)(q24;q32) or other variant of B-ALL | A chromosomal translocation that fuses 8q24 with 14q32. This juxtaposes the MYC gene with the promoter regions of the immunoglobulin heavy chain gene locus, which results in overexpression of Myc proto-oncogene protein in B-cells bearing the translocation. | ncit:C36319 |  |
| t(9;22)(q34;q11.2) ABL/BCR | A translocation between chromosome 9 and chromosome 22 that may be associated with Philadelphia chromosome and increased susceptibility to several types of leukemia. | ncit:C13271 |  |
| Trisomy 10 | A chromosomal abnormality consisting of the presence of a third copy of chromosome 10 in somatic cells. | ncit:C81729 |  |
| Trisomy 17 | A chromosomal abnormality consisting of the presence of a third copy of chromosome 17 in somatic cells. | ncit:C37865 |  |
| Trisomy 4 | A chromosomal abnormality consisting of the presence of a third copy of chromosome 4 in somatic cells. | ncit:C36530 |  |
| CEBPA Mutation - Biallelic | The presence of mutations in both alleles of the CEBPA gene. | ncit:C157569 |  |
| CEBPA Mutation - Monoallelic | The presence of mutations in only one allele of the CEBPA gene. | ncit:C168774 |  |
| CEBPA Mutation - Mutation Unspecified | Mutation of the CEBPA gene encoding CCAAT/enhancer binding protein alpha. It is seen in acute myeloid leukemias usually associated with a normal karyotype. | ncit:C38372 |  |
| CKIT Mutation - Ex17 | A molecular genetic abnormality indicating the presence of a mutation in exon 17 of the KIT gene located within 4q11-q12. | ncit:C116396 |  |
| CKIT Mutation - Ex8 | A molecular genetic abnormality indicating the presence of a mutation in exon 8 of the KIT gene located within 4q11-q12. | ncit:C128660 |  |
| CKIT Mutation - Unspecified | A molecular genetic abnormality that refers to mutation of the c-kit (CD117) proto-oncogene. It is associated with the development of gastrointestinal stromal tumor and gastrointestinal autonomic nerve tumor. It has also been described in acute myeloid leukemias, dysgerminomas, and seminomas. | ncit:C39712 |  |
| del(13q)(13q14-21) | A cytogenetic abnormality that refers to deletion of chromosome bands 14-21 on the long arm of chromosome 13. | ncit:C168770 |  |
| del(17p) | A cytogenetic abnormality that refers to the loss of all or part of the short arm of chromosome 17 (17p). | ncit:C36499 |  |
| del(5q)(5q31-q32) | A cytogenetic abnormality that refers to deletion of chromosome bands 31-32 on the long arm of chromosome 5. | ncit:C168769 |  |
| der.12p | A cytogenetic abnormality involving the rearrangement of two or more other chromosomes with the short arm of chromosome 12 (12p). | ncit:C173542 |  |
| FLT3 Internal Tandem Duplication (ITD) | A genetic abnormality that arises from duplications of the juxtamembrane portion of the gene and results in constitutive activation of the FLT3 receptor tyrosine kinase protein in early hematopoietic progenitor cells. It is associated with acute myelogenous leukemia where it appears to correlate with a poor prognosis. | ncit:C67494 |  |
| FLT3 Tyrosine Kinase Domain (TKD) | Single nucleotide mutations in the tyrosine kinase domain encoded by the human FLT3 gene that are associated with acute myeloid leukemia and poor prognosis. | ncit:C67495 |  |
| GATA1 Mutation | A change in the nucleotide sequence of the GATA1 gene. | ncit:C82340 |  |
| inv(16)(p13.3q24.3) / CBFA2T3-GLIS2 | A pericentric chromosomal inversion that involves chromosome 16. It is associated with CBFA2T3/GLIS2 fusions and pediatric acute megakaryoblastic leukemia. | ncit:C167195 |  |
| inv(16)(p13q22) | A chromosomal inversion that involves chromosome 16. It is associated with the development of acute myeloid leukemia CBFB-MYH11, acute myelomonocytic leukemia with abnormal eosinophils, and granulocytic sarcoma. | ncit:C36373 |  |
| inv(3)(q21.3;q26.2) | A cytogenetic abnormality that refers to a paracentric inversion involving breakpoints on the long (q23.1 and q26.2) of chromosome 3. It is associated with acute myeloid leukemia. | ncit:C36407 |  |
| K-RAS Mutation | A change in the nucleotide sequence of the KRAS gene. | ncit:C41361 |  |
| MLL Other Partner | A chromosomal abnormality consisting of the translocation of genetic material from any one of several chromosomes to the 11q23.3 region, resulting in an MLL gene rearrangement. | ncit:C36517 |  |
| Monosomy 5 | A cytogenetic aneuploidy abnormality that refers to the presence of one chromosome 5 only. It is associated with the development of refractory anemia with excess blasts, refractory anemia with multilineage dysplasia, and refractory anemia with multilineage dysplasia and ringed sideroblasts. | ncit:C36523 |  |
| Monosomy 7 | A chromosomal abnormality consisting of the absence of one of the copies of chromosome 7 in somatic cells. | ncit:C36411 |  |
| N-RAS Mutation | A change in the structure of the NRAS gene. | ncit:C41381 |  |
| Non-KMT2A MLLT10 | An indication that a cytogenetic rearrangement involving MLLT10 but not involving KMT2A was detected in a sample. | ncit:C168771 |  |
| NPM1 Mutation | Mutation of the nucleophosmin gene. It is seen in acute myeloid leukemias usually associated with a normal karyotype. | ncit:C168774 |  |
| PTPN11 Mutation | Mutation of the protein tyrosine phosphatase, non-receptor type 11 gene. It is seen in cases of juvenile myelomonocytic leukemia. | ncit:C82612 |  |
| RUNX1 Mutation | A change in the nucleotide sequence of the RUNX1 gene. | ncit:C38362 |  |
| t(1;11)(q21;q23) / MLL-MLLT11(AF1Q) | A cytogenetic abnormality that refers to the translocation of the long arm (q21) of chromosome 1 and the long arm (q23) of chromosome 11. It is associated with KMT2A (MLL)/MLLT11 (AF1Q) fusions, acute myeloid leukemia and some cases of acute lymphoblastic leukemia. | ncit:C168759 |  |
| t(1;22)(RBM15-MKL1) | A cytogenetic abnormality that refers to the translocation of the short arm (p13.3) of chromosome 1 and the long arm (q13.1) of chromosome 22. It is associated with RBM15/MRTFA (MKL1) fusions and acute megakaryocytic leukemia. | ncit:C36417 |  |
| t(10;11)(p11.2;q23) | A cytogenetic abnormality that refers to the translocation of the short arm (p11.2) of chromosome 10 and the long arm (q23) of chromosome 11. It is associated with KMT2A (MLL)/ABI1 fusions and acute myeloid leukemia. | ncit:C168758 |  |
| t(10;11)(p12;q23) / MLL-MLLT10(AF10) | A cytogenetic abnormality that refers to the translocation of chromosome 10p12 with chromosome 11q23. It is associated with acute myeloid leukemia in childhood. | ncit:C132102 |  |
| t(11;15)(p15;q35) / NUP98/JARID1A | A cytogenetic abnormality that refers to the translocation of chromosome 11p15 with chromosome 15q35. It results in the formation of NUP98/JARID1A fusion gene. It is associated with the development of acute myeloid leukemia with t(11;15)(p15;q35); NUP98-JARID1A. | ncit:C131505 |  |
| t(11;17)(AF17) | A cytogenetic abnormality that refers to the translocation of the long arm (q23) of chromosome 11 and the long arm (q12-21) of chromosome 19. It is associated with KMT2A (MLL) fusions, including those with MLLT6 (AF17), and acute myeloid leukemia. | ncit:C168760 |  |
| t(11;19)(q23;p13.1) / (MLL-ELL) | A cytogenetic abnormality that refers to the translocation of the long arm (q23) of chromosome 11 and the short arm (p13.1) of chromosome 19. It is associated with the development of acute myeloid leukemia with variant MLL translocations and topoisomerase II inhibitor-related acute myeloid leukemia. | ncit:C36371 |  |
| t(11;19)(q23;p13.3) / (MLL-ENL) | A cytogenetic abnormality that refers to the translocation of the long arm (q23.3) of chromosome 11 and the short arm (p13.3) of chromosome 19. It is associated with KMT2A (MLL)/MLLT1 (ENL) fusions and acute myeloid leukemia. | ncit:C36372 |  |
| t(11;19)(q23;p13) / (MLL-ENL)/(MLL-ELL) | A cytogenetic abnormality that refers to the translocation of the long arm (q23) of chromosome 11 and the short arm (p13) of chromosome 19. It is associated with KMT2A (MLL) fusions, including those with MLLT1 (ENL) and ELL, and acute myeloid leukemia. | ncit:C168764 |  |
| t(15;17)(q24;q21) | A chromosomal translocation associated with creation of a fusion between the PML and RARA genes. It is seen in variants of acute promyelocytic leukemia. | ncit:C27758 |  |
| t(16;16)(p13.1;q22) | A chromosomal translocation that involves chromosome 16. It is often associated with the development of acute myeloid leukemia CBFB-MYH11, acute myelomonocytic leukemia with abnormal eosinophils, and granulocytic sarcoma. | ncit:C27759 |  |
| t(16;21)(p11;q22) / FUS/ERG | A chromosomal translocation involving the FUS gene on chromosome 16p11 and the ERG gene on chromosome 21q22. | ncit:C36616 |  |
| t(16;21)(q24;q22) / RUNX1-CBFA2T3 | A cytogenetic abnormality that refers to the translocation of the long arm (q24) of chromosome 16 and the long arm (q22) of chromosome 22. It is associated with RUNX1/CBFA2T3 fusions, myelodysplastic syndromes and acute myeloid leukemia. | ncit:C168773 |  |
| t(2;12) | A cytogenetic abnormality that involves a translocation between chromosomes 2 and 12. | ncit:C173543 |  |
| t(3;12)(q23;p12.3)(ETV6/EVI1) | A cytogenetic abnormality that refers to the translocation of the long arm (q23) of chromosome 3 and the shot arm (p12.3) of chromosome 12. It is associated with ETV6/MECOM (EVI1) fusions, myeloproliferative disorders, myelodysplastic syndromes and acute myelogenous leukemia. | ncit:C168766 |  |
| t(3;3)(q21;q26.2), RPN1-EVI1 | A cytogenetic abnormality that refers to the translocation where both breakpoints are on the long arm (q23.1 and q26.2) of chromosome 3. It is associated with acute myeloid leukemia. | ncit:C36406 |  |
| t(3;5)(q25;q34) / NPM1/MLF1 | A cytogenetic abnormality that refers to the translocation of the long arm (q25) of chromosome 3 and the long arm (q34) of chromosome 5. It is associated with the development of acute myeloid leukemia arising from myelodysplastic syndrome, acute myeloid leukemia with multilineage dysplasia, and acute myeloid leukemia with myelodysplasia-related changes. | ncit:C36415 |  |
| t(5;11)(q35;p15) / NSD1/NUP98 | A cytogenetic abnormality that refers to the translocation of chromosome 11p15 with chromosome 5q35. It results in the formation of NUP98/NSD1 fusion gene. It is associated with the development of acute myeloid leukemia with t(5;11)(q35;p15); NUP98-NSD1. | ncit:C131503 |  |
| t(6;11)(q27;q23) / MLL-MLLT4(AF6) | A cytogenetic abnormality that refers to the translocation of the long arm (q27) of chromosome 6 and the long arm (q23) of chromosome 11. It is associated with the development of de novo acute myeloid leukemia. | ncit:C36610 |  |
| t(6;9)(p23;q34) DEK/NUP214 | A cytogenetic abnormality that refers to the translocation of the short arm (p23) of chromosome 6 and the long arm (q34.1) of chromosome 9. It is associated with DEK/NUP214 fusions, acute myeloid leukemia and myelodysplastic syndromes. | ncit:C36532 |  |
| t(7;12)(q36;p13) / HLXB9(MNX1)/ETV6(TEL) | A chromosomal translocation involving the ETV6 gene on chromosome 12p13 and HLXB9 gene on chromosome 7q36. | ncit:C122689 |  |
| t(8;16)MOZ/CBP | A cytogenetic abnormality that refers to the translocation of the short arm (p11.2) of chromosome 8 and the short arm (p13.3) of chromosome 16. It is associated with KAT6A/CREBBP fusions and acute myeloid leukemia. | ncit:C167194 |  |
| t(9;11)(p22;q23) / MLL-MLLT3(AF9) | A cytogenetic abnormality that refers to the translocation of the short arm (p21.3) of chromosome 9 and the long arm (q23.3) of chromosome 11. It is associated with the development of acute myeloid leukemia with the MLLT3-MLL fusion gene transcript. | ncit:C36370 |  |
| t(9;22)(q34;q11.2) / ABL/BCR | A translocation between chromosomes 9 and 22 that is associated with the Philadelphia chromosome. | ncit:C13271 |  |
| Trisomy 8 | A chromosomal abnormality consisting of the presence of a third copy of chromosome 8 in somatic cells. | ncit:C36396 |  |
| WT1 Mutation | A change in the nucleotide sequence of the WT1 gene. | ncit:C146726 |  |
| Other | Different than the one(s) previously specified or mentioned. | ncit:C17649 |  |
| Unknown | Reported as unknown by the data contributor. | ncit:C17998 |  |
| Not Reported | Not provided or available. | ncit:C43234 |  |
| Chromosome 11 Loss | A cytogenic abnormality that refers to loss of all or part of chromosome 11. | ncit:C36549 |  |
| Chromosome 14q Loss | A cytogenetic abnormality that refers to the loss of all or part of the long arm of chromosome 14 (14q). | ncit:C39795 |  |
| CTNNB1 Variant | A change in the nucleotide sequence of the CTNNB1 gene. | ncit:C36659 |  |
| MYC Amplification | A molecular genetic abnormality indicating the presence of multiple copies of the MYC gene. | ncit:C36641 |  |
| MYCN Amplification | A laboratory test in which cells in a sample of tumor tissue or bone marrow are checked to see how many copies of the MYCN gene are in the tumor DNA. |  |  |
| PTCH1 Variant | A change in the nucleotide sequence of the PTCH1 gene. | ncit:C133669 |  |
| SMO Variant | A molecular genetic abnormality that refers to the mutation of the SMO gene located on chromosome 7q32.3. | ncit:C124793 |  |
| SUFU Variant | A change in the nucleotide sequence of the SUFU gene. | ncit:C189843 |  |
| TP53 Variant | A change in the nucleotide sequence of the TP53 gene. | ncit:C118396 |  |
| ACD Variant | A change in the nucleotide sequence of the ACD gene. | ncit:C152088 |  |
| ALK Variant | A molecular genetic abnormality that refers to the presence of a mutation in the ALK gene. | ncit:C81945 |  |
| ANKRD26 Variant | A change in the nucleotide sequence of the ANKRD26 gene. | ncit:C151909 |  |
| t(2;16)(q35;p11) | A chromosomal translocation involving the FEV gene at 2q35 and the FUS gene at 16p11. | ncit:C174465 |  |
| 12q Gain | A chromosomal aberration where there are 3 copies of the long arm of chromosome 12. This aberration is associated with 12q duplication syndrome. | ncit:C36441 |  |
| 16q Loss | A cytogenetic abnormality that refers to the loss of all or part of the long arm of chromosome 16 (16q). | ncit:C36515 |  |
| 1q Gain | A cytogenetic abnormality that refers to allelic gain within the chromosomal arm 1q. | ncit:C36482 |  |
| 8q Gain | A chromosomal abnormality that refers to the gain of genetic material in the long arm of chromosome 8. | ncit:C36488 |  |
| BCOR Rearranged | A molecular abnormality indicating rearrangement of the BCOR gene. | ncit:C174461 |  |
| BCOR-MAML3 | A fusion gene that results from a chromosomal translocation t(X;4)(p11;q31) which fuses part of exon 15 of the BCOR gene in frame with exon 2 of the MAML3 gene. This fusion is associated with undifferentiated small blue round cell sarcomas. | ncit:C174487 |  |
| CCNB3-BCOR | A fusion gene that results from a paracentric chromosomal inversion inv(X)(p11.4;p11.22) which fuses the stop codon of the BCOR gene to exon 5 of the CCNB3 gene. This fusion is associated with bone sarcomas. | ncit:C139666 |  |
| CDKN2A | A change in the nucleotide sequence of the CDKN2A gene. | ncit:C128817 |  |
| CIC Rearranged | A molecular abnormality indicating rearrangement of the CIC gene. | ncit:C165668 |  |
| CIC-DUX4 | A fusion gene that results from a chromosomal translocation t(4;19)(q35;q13) which fuses exon 20 of the CIC gene to exon 1 of the DUX4 gene. This fusion is associated with soft tissue sarcoma. | ncit:C139663 |  |
| CIC-DUX4L10 | A fusion gene that results from a chromosomal translocation t(10;19)(q26;q13) which fuses the CIC gene to the DUX4L10 gene, a pseudogene that is member of the DUX4L gene family cluster found at 10q26. This fusion is associated with the CIC-rearranged small blue round cell subtype of soft tissue sarcoma. | ncit:C174463 |  |
| EWSR1 Rearranged | A molecular abnormality indicating rearrangement of the EWSR1 gene. | ncit:C165667 |  |
| EWSR1-ATF1 | A fusion gene that results from a chromosomal translocation t(12;22)(q13;q12) which fuses the first 7 or 8 exons of the EWSR1 gene on the 5' side of exon 4 or 5 of the ATF1 gene. This rearrangement is associated with both malignant clear cell sarcoma of the soft tissue and angiomatoid fibrous histiocytoma. | ncit:C99216 |  |
| EWSR1-CREB1 | A fusion gene that results from a chromosomal translocation t(2;22)(q34;q12) which fuses the first 7 exons of the EWSR1 gene to the 5' side of exon 7 of the CREB1 gene. This rearrangement is associated with angiomatoid fibrous histiocytoma and rare cases of malignant clear cell sarcoma of the soft tissue. | ncit:C99249 |  |
| EWSR1-DDIT3 | A fusion gene that results from a chromosomal translocation t(12;22)(q13;p11) which fuses either the first 7 or the first 10 exons of the EWSR1 gene with exon 2 of the DDIT3 gene. This rearrangement is associated with myxoid liposarcoma. | ncit:C99200 |  |
| EWSR1-ERG | A fusion gene that results from a chromosomal translocation t(21;22)(q21;q12) which fuses the EWSR1 gene with the ERG gene. This rearrangement is associated with both Ewing tumor/peripheral primitive neuroectodermal tumor and desmoplastic small round cell sarcoma. | ncit:C99211 |  |
| EWSR1-ETV1 | A fusion gene that results from a chromosomal translocation t(7;22)(p22;q12) which fuses exon 7 of the EWSR1 gene to either exon 10 or 11 of the ETV1 gene. This rearrangement is associated with Ewing sarcoma. | ncit:C99259 |  |
| EWSR1-ETV4 | A fusion gene (~2.1 kb) that results from a chromosomal translocation t(17;22)(q21;q12) which fuses the first seven exons of the EWSR1 gene to the last 6 exons of the ETV4 gene. This rearrangement is associated with Ewing sarcoma. | ncit:C99262 |  |
| EWSR1-FEV | A fusion gene that results from a chromosomal translocation t(2;22)(q36;q12) which fuses either the first seven or ten exons of the EWSR1 gene with exon 1 or 2 of the FEV gene. This rearrangement is associated with Ewing tumor/peripheral primitive neuroectodermal tumor. | ncit:C99226 |  |
| EWSR1-FLI1 | A fusion gene that results from a chromosomal translocation t(11;22)(q24;q12) which fuses the first seven or ten exons of the EWSR1 gene with exon 5, 6 or 8 of the FLI1 gene. This rearrangement is associated with Ewing tumor/peripheral primitive neuroectodermal tumor. | ncit:C99202 |  |
| EWSR1-KLF17 | A rare fusion gene that results from a chromosomal translocation t(1;22)(p34;q12) which fuses portions of the EWSR1 gene with the 5'-untranslated region of the KLF17 gene. This rearrangement is associated with myoepithelial tumors of soft tissue and bone. | ncit:C174474 |  |
| EWSR1-NR4A3 | A fusion gene that results from a chromosomal translocation t(9;22)(q22-31;q11-12) which fuses the first half of the EWSR1 gene to the entire coding sequence of the NR4A3 gene. This rearrangement is associated with extraskeletal myxoid chondrosarcomas. | ncit:C99252 |  |
| EWSR1-PBX1 | A fusion gene that results from a chromosomal translocation t(1;22)(q23;q12) which fuses exon 8 of the EWSR1 gene to exon 5 of the PBX1 gene. This fusion may be associated with myoepithelioma. | ncit:C139668 |  |
| EWSR1-POU5F1 | A fusion gene that results from a chromosomal translocation t(6;22)(p21;q12) which fuses the first six exons of the EWSR1 gene to exon 2 of the POU5F1 gene. This rearrangement is associated with hidradenoma and one case of mucoepidermoid carcinoma of the salivary glands. | ncit:C99256 |  |
| EWSR1-WT1 | A fusion gene that results from a chromosomal translocation t(11;22)(p13;q12) which fuses the intron between exons 7 and 8 of the EWSR1 gene with the intron between exons 7 and 8 of the WT1 gene. This rearrangement is associated with desmoplastic small round cell sarcoma. | ncit:C99213 |  |
| EWSR1-ZNF444 | A fusion gene that results from a chromosomal translocation t(19;22)(q13;q12) which fuses exon 8 of the EWSR1 gene to exon 5 of the ZNF444 gene. This fusion may be associated with myoepithelioma. | ncit:C139731 |  |
| FUS Rearranged | A molecular abnormality indicating rearrangement of the FUS gene. | ncit:C174462 |  |
| FUS Translocation Present | A cytogenetic abnormality that refers to any translocation involving the FUS gene. | ncit:C168530 |  |
| FUS-DDIT3 | A fusion gene that results from a chromosomal translocation t(12;16)(q13;p11) which fuses either the first 5, 7 or 8 exons of the FUS gene with exon 2 of the DDIT3 gene. This rearrangement is associated with myxoid liposarcoma. | ncit:C99279 |  |
| FUS-ERG | A fusion gene that results from a chromosomal translocation t(16;21)(p11;q22) which fuses the FUS gene with the ERG gene. This rearrangement is associated with acute myeloid leukemia. | ncit:C99281 |  |
| FUS-FEV | A fusion gene that results from a chromosomal translocation t(2;16)(q35;p11) which fuses exon 10 of the FUS gene with exon 2 of the FEV gene. This rearrangement is associated with Ewing sarcoma. | ncit:C174466 |  |
| FUS-KLF17 | A fusion gene that results from a chromosomal translocation t(1;16)(p34;p11) which fuses either intron 4 or exon 6 of the FUS gene with 5'-untranslated region of the KLF17 gene. This rearrangement is associated with myoepithelial tumors of soft tissue and bone. | ncit:C174473 |  |
| inv(X)(p11.4;p11.22) | A paracentric chromosomal inversion of the short arm of the X chromosome involving the BCOR gene at Xp11.4 and the CCNB3 gene at Xp11.22. | ncit:C174489 |  |
| STAG2 | A change in the nucleotide sequence of the STAG2 gene. | ncit:C153513 |  |
| t(1;16)(p34;p11) | A chromosomal translocation involving the KLF17 gene at 1p34 and the FUS gene at 16p11. | ncit:C174475 |  |
| t(1;22)(p34;q12) | A chromosomal translocation involving the KLF17 gene at 1p34 and the EWSR1 gene at 22q12. | ncit:C174476 |  |
| t(1;22)(q23;q12) | A chromosomal translocation involving the PBX1 gene at 1q23 and the EWSR1 gene at 22q12. | ncit:C174477 |  |
| t(10;19)(q26;q13) | A cytogenetic abnormality that refers to the translocation involving the genes CIC (capicua transcriptional suppressor) on chromosome 19 and DUX4L (double homeobox 4-like) on chromosome 10 resulting in CIC-DUX4L fusion. | ncit:C120223 |  |
| t(11;22)(p13;q12) | A chromosomal translocation involving the WT1 gene on chromosome 11p31 and the EWSR1 gene on chromosome 22q12. | ncit:C36375 |  |
| t(11;22)(q24;q12) | A chromosomal translocation involving the FLI1 gene on chromosome 11q24 and the EWSR1 gene on chromosome 22q12. | ncit:C27214 |  |
| t(12;16)(q13;p11) | A chromosomal translocation that involves chromosome 12 and chromosome 16. It is often associated with the development of angiomatoid fibrous histiocytoma or myxoid liposarcoma. | ncit:C36317 |  |
| t(12;22)(q13.12;q12) | A chromosomal translocation involving the ATF1 gene at 12q13.12 and the EWSR1 gene at 22q12. | ncit:C174478 |  |
| t(12;22)(q13.3;q12) | A chromosomal translocation involving the DDIT3 gene at 12q13.3 and the EWSR1 gene at 22q12. | ncit:C174479 |  |
| t(17;22)(q21;q12) | A chromosomal translocation involving the ETV4 gene on chromosome 17q21 and the EWSR1 gene on chromosome 22q12. | ncit:C36369 |  |
| t(19;22)(q13;q12) | A chromosomal translocation involving the ZNF444 gene at 19q13 and the EWSR1 gene at 22q12. | ncit:C174480 |  |
| t(2;22)(q33;q12) | A chromosomal translocation involving the CREB1 gene on chromosome 2q33 and the EWSR1 gene on chromosome 22q12. | ncit:C37249 |  |
| t(2;22)(q34;q12) | A chromosomal translocation involving the CREB1 gene at 2q34 and the EWSR1 gene at 22q12. | ncit:C174481 |  |
| t(16;21)(p11;q22) | A chromosomal translocation involving the FUS gene on chromosome 16p11 and the ERG gene on chromosome 21q22. | ncit:C36616 |  |
| t(21;22)(q22;q12) | A chromosomal translocation associated with Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor and Olfactory Neuroblastoma. | ncit:C36367 |  |
| t(4;19)(q25;q13) | A chromosomal translocation involving the CIC gene at 19q13 and a second breakpoint on the long arm of chromosome 4 (4q25). | ncit:C174482 |  |
| t(4;19)(q35;q13) | A cytogenetic abnormality that refers to the translocation involving the genes CIC (capicua transcriptional suppressor) on chromosome 19 and DUX4 (double homeobox 4) on chromosome 4 resulting in CIC-DUX4 fusion. | ncit:C120222 |  |
| t(6;22)(p21;q12) | A chromosomal translocation involving the POU5F1 gene at 6p21 and the EWSR1 gene at 22q12. | ncit:C174483 |  |
| t(7;22)(p22;q12) | A cytogenetic abnormality that refers to the translocation of the short arm (p22) of chromosome 7 and the long arm (q12) of chromosome 22. | ncit:C36368 |  |
| t(9;17)(q22;q11) | A chromosomal translocation involving the NR4A3 gene on chromosome 9q31 and the TAF15 gene on chromosome 17q12. | ncit:C36393 |  |
| t(9;22)(q22;q12) | A chromosomal translocation involving the NR4A3 gene at 9q22 and the EWSR1 gene at 22q12. | ncit:C174484 |  |
| t(X;22((p11;q13) | A chromosomal translocation involving the BCOR gene at Xp11 and the ZC3H7B gene at 22q13. | ncit:C174495 |  |
| t(X;4)(p11;q31) | A chromosomal translocation involving the BCOR gene at Xp11 and the MAML3 gene at 4q31. | ncit:C174490 |  |
| TAF15-NR4A3 | A fusion gene that results from a chromosomal translocation t(9;17)(q22;q11) which fuses exon 6 of the TAF15 gene to the entire coding sequence of the NR4A3 gene. This rearrangement is associated with extraskeletal myxoid chondrosarcoma. | ncit:C99501 |  |
| TP53 | A change in the nucleotide sequence of the TP53 gene. | ncit:C118396 |  |
| ZC3H7B-BCOR | A fusion gene that results from a chromosomal translocation t(X;22)(p11;q13) which fuses exon 10 of the ZC3H7B gene to either exon 7 or 8 of the BCOR gene. This fusion is associated with both undifferentiated small blue round cell sarcomas and endometrial stromal sarcomas. | ncit:C174491 |  |
| 45XO | Gonadal dysgenesis in an individual with 46,XX karyotype and female phenotype. | ncit:C26900 |  |
| 45XO w/ Y chromosomal material | An abnormal sex chromosome karyotype where the individual is missing a second X chromosome and has some chromosomal material from the Y chromosome. The normal autosomal karyotype is present. | ncit:C176781 |  |
| 46XX | Gonadal dysgenesis in an individual with 46,XX karyotype and female phenotype. | ncit:C120197 |  |
| 46XY | Gonadal dysgenesis in an individual with 46.XY karyotype. | ncit:C120198 |  |
| 47XYY | A condition caused by the presence of an extra Y chromosome resulting in 47,XYY karyotype in an individual with male phenotype. The condition is characterized by tall stature, increased risk of learning disabilities, and delayed development of speech and language. Testicular function and size are normal. | ncit:C85237 |  |
| 47XXY | A sex chromosome disorder caused by the presence of an extra X chromosome in the male karyotype. Affected individuals are infertile and have a small penis and testes. They tend to have tall stature and long legs and may have difficulties with speech and language development. Gynecomastia may be present. | ncit:C34752 |  |
| 47XXX | A condition caused by the presence of an extra X chromosome resulting in 47,XXX karyotype in an individual with female phenotype. The condition is characterized by tall stature, increased risk of learning disabilities, and delayed development of speech and language. | ncit:C129718 |  |
| 48XXXY | A rare sex chromosome abnormality in which a male child has 2 extra X chromosomes. | ncit:C89799 |  |
| 48XXXX | An abnormal sex chromosome karyotype where the individual has four copies of the X chromosome. The normal autosomal karyotype is present. | ncit:C176787 |  |
| p.G1128A | ALK alterations that result in the amino acid substitution of G -> A at 1128 |  |  |
| p.M1166R | ALK alterations that result in the amino acid substitution of M -> R at 1166 |  |  |
| p.I1170N | ALK alterations that result in the amino acid substitution of I -> N at 1170 |  |  |
| p.I1170S | ALK alterations that result in the amino acid substitution of I -> S at 1170 |  |  |
| p.I1171N | ALK alterations that result in the amino acid substitution of I -> N at 1171 |  |  |
| p.F1174* | ALK alterations that result in the amino acid substitution of F -> [one of several other amino acids] at 1174 |  |  |
| p.R1192P  | ALK alterations that result in the amino acid substitution of R -> P at 1192 |  |  |
| p.L1196M  | ALK alterations that result in the amino acid substitution of L -> M at 1196 |  |  |
| p.F1245* | ALK alterations that result in the amino acid substitution of F -> [one of several other amino acids] at 1245 |  |  |
| p.R1275* | ALK alterations that result in the amino acid substitution of R -> [one of several other amino acids] at 1275 |  |  |
| p.Y1278S | ALK alterations that result in the amino acid substitution of Y -> S at 1278 |  |  |
| ALK Missense, NOS | ALK missense alterations that that do not result in any of the above amino acid substitutions and do not amplify the copy number |  |  |
| ALK Amplification, NOS | ALK alterations that are not missense and do amplify the copy number |  |  |
| ALK Alteration, NOS | ALK alterations that are not missense and do not amplify the copy number |  |  |
| None | Nothing was identified. | ncit:C157432 |  |
| RB1 Allele 1 | The RB1 gene provides instructions for making a protein called pRB. This protein acts as a tumor suppressor, which means that it regulates cell growth and keeps cells from dividing too fast or in an uncontrolled way. |  |  |
| Chromosome 1q Gain (KIF14 Gain) | A cytogenetic abnormality that refers to allelic gain within the chromosomal arm 1q. KIF14 affects cell cycle arrest and cell viability in cervical cancer by regulating the p27(Kip1) pathway. |  |  |
| Chromosome 2p Gain (MYCN Gain) | A cytogenetic abnormality that refers to the duplication of all or part of the short arm of chromosome 2. MYCN gene is involved in transcriptional regulation and amplification of this gene is associated with a variety of tumors, most notably neuroblastomas. |  |  |
| Chromosome 6p Gain (DEK/E2F3 Gain) | A chromosomal abnormality that refers to the gain of genetic material in the short arm of chromosome 6. DEK is a structurally unique and highly conserved protein with emerging roles in epigenetic and transcriptional regulation. E2F-3 regulates the expression of genes that determine the rate of proliferation of both primary and tumor cell lines. |  |  |
| Chromosome 16q Loss (CDH11 Loss) | A cytogenetic abnormality that refers to the loss of all or part of the long arm of chromosome 16 (16q). CDH11 Gene is involved in the adherens junction.  |  |  |

